Latest News about ALLO
Recent news which mentions ALLO
From Benzinga
What 5 Analyst Ratings Have To Say About Allogene Therapeutics
August 10, 2022
Tickers
ALLO
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
August 10, 2022
From Benzinga
Why Beam Therapeutics Stock Dipped Today
August 01, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
March 23, 2022
From Benzinga
Why Cellectis Stock Rose 20.7% This Week
March 10, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
From Benzinga
FDA Lifts Clinical Hold On Allogene's CAR-T Trials
January 11, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 20, 2021
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 13, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
From InvestorPlace
Cathie Wood's Buying Beam Therapeutics -- Should You?
November 09, 2021
From Motley Fool
Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
ALLO
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.